Cargando…
Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report
BACKGROUND: All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare but potentially fatal complication of differentiation syndrome. While the presentation of this syndrom...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609250/ https://www.ncbi.nlm.nih.gov/pubmed/34814948 http://dx.doi.org/10.1186/s40959-021-00124-9 |
_version_ | 1784602890419044352 |
---|---|
author | Shenoy, Shabari Mangalore Di Vitantonio, Thomas Plitt, Anna Perez-Johnston, Rocio Gutierrez, Jillian Knorr, David A. Stein, Eytan M. Liu, Jennifer E. Feldman, Stephanie |
author_facet | Shenoy, Shabari Mangalore Di Vitantonio, Thomas Plitt, Anna Perez-Johnston, Rocio Gutierrez, Jillian Knorr, David A. Stein, Eytan M. Liu, Jennifer E. Feldman, Stephanie |
author_sort | Shenoy, Shabari Mangalore |
collection | PubMed |
description | BACKGROUND: All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare but potentially fatal complication of differentiation syndrome. While the presentation of this syndrome is varied, myopericarditis as a manifestation of differentiation syndrome is often fatal and rarely reported in literature. We present a case of myopericarditis as the sole manifestation of differentiation syndrome in a patient on induction therapy with ATRA and arsenic trioxide for APL. CLINICAL PRESENTATION: A 62 year old woman with remote history of breast and uterine cancer presented to the hospital for expedited work up of easy bruising and expanding hematomas. She was diagnosed with APL with peripheral blood and bone marrow cytogenetics revealing t (15;17) translocation and initiated on induction therapy with ATRA and ATO as well as steroids for differentiation syndrome prophylaxis. Eighteen days into induction therapy, patient developed pleuritic chest pain, elevated cardiac biomarkers, ECG changes suggestive of pericarditis. Cardiac magnetic resonance imaging showed patchy multifocal sub-epicardial late gadolinium enhancement and elevated T2 signal consistent with acute myopericarditis. Given the timing of symptom onset and lack of other identifiable cause, patient was diagnosed with differentiation syndrome- induced myopericarditis and promptly initiated on high dose steroids with rapid improvement in symptoms, ECG, and cardiac biomarkers. Patient successfully resumed dose-reduced ATRA and arsenic trioxide without complication. CONCLUSION: Myopericarditis can be the sole manifestation of differentiation syndrome and the presentation may be atypical owing to the use of prophylactic steroids as illustrated in our patient’s case. A high index of suspicion for differentiation syndrome, multimodality imaging, and prompt input from multidisciplinary providers is crucial for making the timely diagnosis and initiating life-saving treatment. |
format | Online Article Text |
id | pubmed-8609250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86092502021-11-23 Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report Shenoy, Shabari Mangalore Di Vitantonio, Thomas Plitt, Anna Perez-Johnston, Rocio Gutierrez, Jillian Knorr, David A. Stein, Eytan M. Liu, Jennifer E. Feldman, Stephanie Cardiooncology Case Report BACKGROUND: All trans retinoic acid (ATRA) has revolutionized the treatment and outcomes of patients with Acute Promyelocytic Leukemia (APL). Induction therapy with ATRA is associated with the rare but potentially fatal complication of differentiation syndrome. While the presentation of this syndrome is varied, myopericarditis as a manifestation of differentiation syndrome is often fatal and rarely reported in literature. We present a case of myopericarditis as the sole manifestation of differentiation syndrome in a patient on induction therapy with ATRA and arsenic trioxide for APL. CLINICAL PRESENTATION: A 62 year old woman with remote history of breast and uterine cancer presented to the hospital for expedited work up of easy bruising and expanding hematomas. She was diagnosed with APL with peripheral blood and bone marrow cytogenetics revealing t (15;17) translocation and initiated on induction therapy with ATRA and ATO as well as steroids for differentiation syndrome prophylaxis. Eighteen days into induction therapy, patient developed pleuritic chest pain, elevated cardiac biomarkers, ECG changes suggestive of pericarditis. Cardiac magnetic resonance imaging showed patchy multifocal sub-epicardial late gadolinium enhancement and elevated T2 signal consistent with acute myopericarditis. Given the timing of symptom onset and lack of other identifiable cause, patient was diagnosed with differentiation syndrome- induced myopericarditis and promptly initiated on high dose steroids with rapid improvement in symptoms, ECG, and cardiac biomarkers. Patient successfully resumed dose-reduced ATRA and arsenic trioxide without complication. CONCLUSION: Myopericarditis can be the sole manifestation of differentiation syndrome and the presentation may be atypical owing to the use of prophylactic steroids as illustrated in our patient’s case. A high index of suspicion for differentiation syndrome, multimodality imaging, and prompt input from multidisciplinary providers is crucial for making the timely diagnosis and initiating life-saving treatment. BioMed Central 2021-11-23 /pmc/articles/PMC8609250/ /pubmed/34814948 http://dx.doi.org/10.1186/s40959-021-00124-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Shenoy, Shabari Mangalore Di Vitantonio, Thomas Plitt, Anna Perez-Johnston, Rocio Gutierrez, Jillian Knorr, David A. Stein, Eytan M. Liu, Jennifer E. Feldman, Stephanie Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title_full | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title_fullStr | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title_full_unstemmed | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title_short | Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report |
title_sort | differentiation syndrome-induced myopericarditis in the induction therapy of acute promyelocytic leukemia: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609250/ https://www.ncbi.nlm.nih.gov/pubmed/34814948 http://dx.doi.org/10.1186/s40959-021-00124-9 |
work_keys_str_mv | AT shenoyshabarimangalore differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT divitantoniothomas differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT plittanna differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT perezjohnstonrocio differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT gutierrezjillian differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT knorrdavida differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT steineytanm differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT liujennifere differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport AT feldmanstephanie differentiationsyndromeinducedmyopericarditisintheinductiontherapyofacutepromyelocyticleukemiaacasereport |